Isosorbide mononitrate and Salvia analysis of freeze-dried powder in treatment of pulmonary heart disease.docVIP

 PAGE \* MERGEFORMAT 6 Isosorbide mononitrate and Salvia analysis of freeze-dried powder in treatment of pulmonary heart disease [Keywords:] Salvia Pulmonary heart disease Referred to as pulmonary heart disease Pulmonary heart disease is defined by bronchial - lung tissue, thoracic or pulmonary vascular disease caused by increased pulmonary vascular resistance, resulting in pulmonary hypertension, followed by right ventricular structure or (and) functional changes of the disease. Our hospital in November 2006 -2,008 of the Year in November admitted 102 patients with pulmonary heart disease patients application of isosorbide mononitrate and Salvia freeze-dried powder, and achieved good effect. Reported as follows. A clinical data 1.1 Case Selection 102 patients were hospital inpatients, are in line with the country in 1982 revised diagnostic criteria for pulmonary heart disease and practical science of the eighth edition in the diagnosis of right heart failure. 102 cases of patients, 57 cases of males and 45 females, aged 53 to 78 years old, 89 cases aged over 60 years old. 102 patients were randomly divided into two groups, one group for the treatment group, another group as the control group, 51 patients in each group. 1.2 treatment groups were given oxygen, anti-infection, correct acid-base imbalance and electrolyte disturbance. The treatment group with isosorbide mononitrate 20mg adding 5% GS250ml slow infusion, Salvia 800mg of freeze-dried powder by adding 5% GS250ml infusion, continuous application of 7 to 10 days. Anti-heart failure control group was given digitalis therapy. 1.3 efficacy criterion-referenced the Ministry of Health in February 1981 recommended ‘treatment effect assessment standards’. Improved: remission, improved cardiac function, heart failure to reduce a sub-degree or more; invalid: the symptoms are not relieved to reduce heart failure less than a sub-degree; worse: the symptoms intensified, aggravated heart failure. 2 Results Tr